MPP PHARMA
GenericsMPP PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.
MPP PHARMA's Key Drugs
MPP PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MPP PHARMA's Recent FDA Approvals
New NDA/BLA approvals for MPP PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
MPP PHARMA's Therapeutic Areas
MPP PHARMA's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MPP PHARMA's Top Competitors
MPP PHARMA's closest competitors by therapeutic-area and drug-target overlap include Baxter, AbbVie, and WARNER CHILCOTT. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MPP PHARMA Pipeline Snapshot
Active clinical trials for MPP PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1959-08-06
- Latest
- 2025-07-25
- Applications
- 18